{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:28:09Z","timestamp":1779344889361,"version":"3.51.4"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroRX"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.nurx.2006.05.007","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T17:21:36Z","timestamp":1151774496000},"page":"302-318","source":"Crossref","is-referenced-by-count":70,"title":["Single cell gene expression profiling in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoli","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Counts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30300302_CR1","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1001\/jama.262.16.2256","volume":"262","author":"DA Evans","year":"1989","unstructured":"Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer\u2019s disease in a community population of older persons: higher than previously reported.JAMA 262: 2256\u20132551, 1989.","journal-title":"JAMA"},{"key":"30300302_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","volume":"15","author":"LE Hebert","year":"2001","unstructured":"Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer\u2019s disease in the United States projected to the years 2000 through 2050.Alzheimer Dis Assoc Disord 15: 169\u2013173, 2001.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"30300302_CR3","first-page":"203","volume-title":"Cerebral cortex: neurodegenerative and age-related changes in structure and function of cerebral cortex","author":"SD Ginsberg","year":"1999","unstructured":"Ginsberg SD, Schmidt ML, Crino PB, Eberwine JH, Lee VM-Y, Trojanowski JQ. Molecular pathology of Alzheimer\u2019s disease and related disorders. In: Cerebral cortex: neurodegenerative and age-related changes in structure and function of cerebral cortex (Peters A, Morrison JH, eds), Vol 14, pp 203\u2013653. New York: Kluwer Academic\/Plenum, 1999."},{"key":"30300302_CR4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","volume":"275","author":"DJ Selkoe","year":"1997","unstructured":"Selkoe DJ. Alzheimer\u2019s disease: genotypes, phenotypes, and treatments.Science 275: 630\u2013631, 1997.","journal-title":"Science"},{"key":"30300302_CR5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)61206-0","volume":"167","author":"JQ Trojanowski","year":"2005","unstructured":"Trojanowski JQ, Lee VM. The Alzheimer\u2019s brain: finding out what\u2019s broken tells us how to fix it.Am J Pathol 167: 1183\u20131188, 2005.","journal-title":"Am J Pathol"},{"key":"30300302_CR6","volume-title":"Neurobiology of Alzheimer\u2019s disease","author":"EJ Mufson","year":"2006","unstructured":"Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD. NGF family of neurotrophins and their receptors: early involvement in the progression of Alzheimer\u2019s disease. In Neurobiology of Alzheimer\u2019s disease 3rd ed. (Dawbarn D, Allen SJ, eds), Oxford, UK: Oxford University Press, 2006.","edition":"3rd ed"},{"key":"30300302_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-4886(89)90124-6","volume":"105","author":"EJ Mufson","year":"1989","unstructured":"Mufson EJ, Bothwell M, Kordower JH. Loss of nerve growth factor receptor-containing neurons in Alzheimer\u2019s disease: a quantitative analysis across subregions of the basal forebrain.Exp Neurol 105: 221\u2013232, 1989.","journal-title":"Exp Neurol"},{"key":"30300302_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cne.902850204","volume":"285","author":"EJ Mufson","year":"1989","unstructured":"Mufson EJ, Bothwell M, Hersh LB, Kordower JH. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons.J Comp Neurol 285: 196\u2013217, 1989.","journal-title":"J Comp Neurol"},{"key":"30300302_CR9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Rice DL, Struble RG, Clark AW, Coyle JT, Delong MR. Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain.Science 215: 1237\u20131239, 1982.","journal-title":"Science"},{"key":"30300302_CR10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease.Lancet 2: 1403, 1976.","journal-title":"Lancet"},{"key":"30300302_CR11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, van Hoesen GW, Damasio AR, Barnes CL. Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation.Science 225: 1168\u20131170, 1984.","journal-title":"Science"},{"key":"30300302_CR12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1212\/WNL.40.11.1721","volume":"40","author":"BT Hyman","year":"1990","unstructured":"Hyman BT, van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer\u2019s disease: an anatomic study.Neurology 40: 1721\u20131730, 1990.","journal-title":"Neurology"},{"key":"30300302_CR13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.tins.2004.07.013","volume":"27","author":"PR Hof","year":"2004","unstructured":"Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits.Trends Neurosci 27: 607\u2013613, 2004.","journal-title":"Trends Neurosci"},{"key":"30300302_CR14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"BT Hyman","year":"1997","unstructured":"Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer\u2019s disease.J Neuropathol Exp Neurol 56: 1095\u20131097, 1997.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD): Part II. Standardization of the neuro-pathologic assessment of Alzheimer\u2019s disease.Neurology 41: 479\u2013486, 1991.","journal-title":"Neurology"},{"key":"30300302_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0197-4580(98)00052-9","volume":"19","author":"NC Berchtold","year":"1998","unstructured":"Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer\u2019s disease: Greco-Roman period to the 1960s.Neurobiol Aging 19: 173\u2013189, 1998.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR17","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A. Uber eine eigenartige Erkrangkung der Hirnrinde.All Z Psychiatr 64: 146\u2013148, 1907.","journal-title":"All Z Psychiatr"},{"key":"30300302_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VM-Y, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.Annu Rev Pathol Mech Dis 1: 151\u2013170, 2006.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"30300302_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711510102","volume":"151","author":"AS Cohen","year":"1987","unstructured":"Cohen AS, Connors LH. The pathogenesis and biochemistry of amyloidosis.J Pathol 151: 1\u201310, 1987.","journal-title":"J Pathol"},{"key":"30300302_CR20","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","volume":"34","author":"A Iwai","year":"1995","unstructured":"Iwai A, Yoshimoto M, Masliah E, Saitoh T. Non-A\u03b2 component of Alzheimer\u2019s disease amyloid (NAC) is amyloidogenic.Biochemistry 34: 10139\u201310145, 1995.","journal-title":"Biochemistry"},{"key":"30300302_CR21","first-page":"201","volume":"148","author":"E Masliah","year":"1996","unstructured":"Masliah E, Iwai A, Mallory M, Ueda K, Saitoh T. Altered pre-synaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer\u2019s disease.Am J Pathol 148: 201\u2013210, 1996.","journal-title":"Am J Pathol"},{"key":"30300302_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/exnr.1994.1209","volume":"130","author":"ML Schmidt","year":"1994","unstructured":"Schmidt ML, DiDario AG, Otvos L Jr, Hoshi M, Kant JA, Lee VM-Y, et al. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer\u2019s disease brain.Exp Neurol 130: 311\u2013322. 1994.","journal-title":"Exp Neurol"},{"key":"30300302_CR23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0197-4580(96)00113-3","volume":"17","author":"GM Pasinetti","year":"1996","unstructured":"Pasinetti GM. Inflammatory mechanisms in neurodegeneration and Alzheimer\u2019s disease: the role of the complement system.Neurobiol Aging 17: 707\u2013716, 1996.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0196-9781(02)00070-0","volume":"23","author":"CS Atwood","year":"2002","unstructured":"Atwood CS, Martins RN, Smith MA, Perry G. Senile plaque composition and posttranslational modification of amyloid-\u03b2 pep-tide and associated proteins.Peptides 23: 1343\u20131350, 2002.","journal-title":"Peptides"},{"key":"30300302_CR25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem Biophys Res Commun 120: 885\u2013890, 1984.","journal-title":"Biochem Biophys Res Commun"},{"key":"30300302_CR26","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer\u2019s disease and Down syndrome.Proc Natl Acad Sci USA 82: 4245\u20134249, 1985.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0304-3940(90)90748-X","volume":"119","author":"LS Perlmutter","year":"1990","unstructured":"Perlmutter LS, Barron E, Chui HC. Morphologic association between microglia and senile plaque amyloid in Alzheimer\u2019s disease.Neurosci Lett 119: 32\u201336, 1990.","journal-title":"Neurosci Lett"},{"key":"30300302_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/glia.440070113","volume":"7","author":"DW Dickson","year":"1993","unstructured":"Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan CF. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer\u2019s disease.Glia 7: 75\u201383, 1993.","journal-title":"Glia"},{"key":"30300302_CR29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","volume":"24","author":"S Itagaki","year":"1989","unstructured":"Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer\u2019s disease.J Neuroimmunol 24: 173\u2013182, 1989.","journal-title":"J Neuroimmunol"},{"key":"30300302_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(02)00090-8","volume":"24","author":"AK Vehmas","year":"2003","unstructured":"Vehmas AK, Kawas CH, Stewart WF, Troncoso JC. Immune reactive cells in senile plaques and cognitive decline in Alzheimer\u2019s disease.Neurobiol Aging 24: 321\u2013331, 2003.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410410211","volume":"41","author":"SD Ginsberg","year":"1997","unstructured":"Ginsberg SD, Crino PB, Lee VM-Y, Eberwine JH, Trojanowski JQ. Sequestration of RNA in Alzheimer\u2019s disease neurofibrillary tangles and senile plaques.Ann Neurol 41: 200\u2013209, 1997.","journal-title":"Ann Neurol"},{"key":"30300302_CR32","first-page":"1823","volume":"149","author":"T Iwatsubo","year":"1996","unstructured":"Iwatsubo T, Saido TC, Mann DMA, Lee VM-Y, Trojanowski JQ. Full-length amyloid-\u03b2(1\u201342(43)) and amino-terminally modified and truncated amyloid \u03b242(43) deposit in diffuse plaques.Am J Pathol 149: 1823\u20131830, 1996.","journal-title":"Am J Pathol"},{"key":"30300302_CR33","first-page":"1293","volume":"137","author":"E Masliah","year":"1990","unstructured":"Masliah E, Terry RD, Mallory N, Alford M, Hansen LA. Diffuse plaques do not accentuate synapse loss in Alzheimer\u2019s disease.Am J Pathol 137: 1293\u20131297, 1990.","journal-title":"Am J Pathol"},{"key":"30300302_CR34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.1999.7086","volume":"158","author":"EJ Mufson","year":"1999","unstructured":"Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex \u03b2-amyloid load in individuals with mild cognitive impairment.Exp Neurol 158: 469\u2013490, 1999.","journal-title":"Exp Neurol"},{"key":"30300302_CR35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease.Neurology 60: 1495\u20131500, 2003.","journal-title":"Neurology"},{"key":"30300302_CR36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0306-4522(02)00056-8","volume":"112","author":"T Bussiere","year":"2002","unstructured":"Bussiere T, Friend PD, Sadeghi N Wicinski B Lin Gl, Bouras C, et al. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer\u2019s disease.Neuroscience 112: 75\u201391, 2002.","journal-title":"Neuroscience"},{"key":"30300302_CR37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal A\u03b2 causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice.Neuron 45: 675\u2013688, 2005.","journal-title":"Neuron"},{"key":"30300302_CR38","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, et al. Intraneuronal Alzheimer A(\u03b2)42 accumulates in multivesicular bodies and is associated with synaptic pathology.Am J Pathol 161: 1869\u20131879, 2002.","journal-title":"Am J Pathol"},{"key":"30300302_CR39","doi-asserted-by":"crossref","first-page":"14786","DOI":"10.1074\/jbc.270.24.14786","volume":"270","author":"AJ Yang","year":"1995","unstructured":"Yang AJ, Knauer M, Burdick DA, Glabe C. Intracellular A\u03b2 1\u201342 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells.J Biol Chem 270: 14786\u201314792, 1995.","journal-title":"J Biol Chem"},{"key":"30300302_CR40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","volume":"165","author":"C Casas","year":"2004","unstructured":"Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, et al. Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated A\u03b242 accumulation in a novel Alzheimer transgenic model.Am J Pathol 165: 1289\u20131300, 2004.","journal-title":"Am J Pathol"},{"key":"30300302_CR41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/exnr.1997.6777","volume":"150","author":"JB Leverenz","year":"1998","unstructured":"Leverenz JB, Raskind MA. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis.Exp Neurol 150: 296\u2013304, 1998.","journal-title":"Exp Neurol"},{"key":"30300302_CR42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0387-7604(02)00209-7","volume":"25","author":"A Hirayama","year":"2003","unstructured":"Hirayama A, Horikoshi Y, Maeda M, Ito M, Takashima S. Characteristic developmental expression of amyloid \u03b240, 42 and 43 in patients with Down syndrome.Brain Dev 25: 180\u2013185, 2003.","journal-title":"Brain Dev"},{"key":"30300302_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Meur NL, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer\u2019s disease with cerebral amyloid angiopathy.Nat Genet 38: 24\u201326, 2006.","journal-title":"Nat Genet"},{"key":"30300302_CR44","doi-asserted-by":"crossref","first-page":"18295","DOI":"10.1074\/jbc.271.31.18295","volume":"271","author":"DJ Selkoe","year":"1996","unstructured":"Selkoe DJ. Amyloid-\u03b2-protein and the genetics of Alzheimer\u2019s disease.J Biol Chem 271: 18295\u201318298, 1996.","journal-title":"J Biol Chem"},{"key":"30300302_CR45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease.Nature 349: 704\u2013706, 1991.","journal-title":"Nature"},{"key":"30300302_CR46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate A\u03b21\u201342\/40 ratioin vitro and in vivo.Neuron 17: 1005\u20131013, 1996.","journal-title":"Neuron"},{"key":"30300302_CR47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein.Nature 373: 523\u2013527, 1995.","journal-title":"Nature"},{"key":"30300302_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice.Science 274: 99\u2013102, 1996.","journal-title":"Science"},{"key":"30300302_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","volume":"6","author":"U Finckh","year":"2005","unstructured":"Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, et al. Novel mutations and repeated findings of mutations in familial Alzheimer\u2019s disease.Neurogenetics 6: 85\u201389. 2005.","journal-title":"Neurogenetics"},{"key":"30300302_CR50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene.Nature 376: 775\u2013778, 1995.","journal-title":"Nature"},{"key":"30300302_CR51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease.Nature 375: 754\u2013760. 1995.","journal-title":"Nature"},{"key":"30300302_CR52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nm0296-224","volume":"2","author":"DM Kovacs","year":"1996","unstructured":"Kovacs DM, Fausett HJ, Page KJ, Kim T-W, Moir RD, Merriam DE, et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.Nat Med 2: 224\u2013229, 1996","journal-title":"Nat Med"},{"key":"30300302_CR53","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1523\/JNEUROSCI.17-06-01971.1997","volume":"17","author":"JJ Lah","year":"1997","unstructured":"Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, Counts SE, et al. Light and electron microscopic localization of presenilin-1 in primate brain.J Neurosci 17: 1971\u20131980, 1997.","journal-title":"J Neurosci"},{"key":"30300302_CR54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.conb.2004.05.010","volume":"14","author":"T Iwatsubo","year":"2004","unstructured":"Iwatsubo T. The gamma-secretase complex: machinery for intramembrane proteolysis.Curr Opin Neurobiol 14: 379\u2013383, 2004.","journal-title":"Curr Opin Neurobiol"},{"key":"30300302_CR55","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M304009200","volume":"278","author":"SH Pasternak","year":"2003","unstructured":"Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, et al. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane.J Biol Chem 278: 26687\u201326894, 2003.","journal-title":"J Biol Chem"},{"key":"30300302_CR56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","volume":"383","author":"K Duff","year":"1996","unstructured":"Duff K, Eckman C, Zehr C, Yu X, Prada C-M, Perez-tur J, et al. Increased amyloid-\u03b242(43) in brains of mice expressing mutant presenilin 1.Nature 383: 710\u2013713, 1996.","journal-title":"Nature"},{"key":"30300302_CR57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W, Carlson G, Levesque G, Johnson-Wood K, et al. Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice.Nat Med 3: 67\u201372, 1997.","journal-title":"Nat Med"},{"key":"30300302_CR58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Okada A, Suzuki N, Mizusawa N, Nukina N, Ihara Y. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43).Neuron 13: 45\u201353, 1994.","journal-title":"Neuron"},{"key":"30300302_CR59","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease.Biochemistry 32: 4693\u20134697, 1993.","journal-title":"Biochemistry"},{"key":"30300302_CR60","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9440(10)63185-9","volume":"164","author":"L-W Jin","year":"2004","unstructured":"Jin L-W, Maezawa I, Vincent I, Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-{\u03b2} precursor protein in neurons with Niemann-Pick Type C defects is associated with endosomal abnormalities.Am J Pathol 164: 975\u2013985, 2004.","journal-title":"Am J Pathol"},{"key":"30300302_CR61","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1067\/mhj.2000.108946","volume":"140","author":"ER Hauser","year":"2000","unstructured":"Hauser ER, Pericak-Vance MA. Genetic analysis for common complex disease.Am Heart J 140: S36-S44, 2000.","journal-title":"Am Heart J"},{"key":"30300302_CR62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0959-437X(95)80047-6","volume":"5","author":"DR Bently","year":"1995","unstructured":"Bently DR, Dunham I. Mapping human chromosomes.Curr Opin Genet Dev 5: 328\u2013334, 1995.","journal-title":"Curr Opin Genet Dev"},{"key":"30300302_CR63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0531-5565(00)00196-0","volume":"35","author":"MA Pericak-Vance","year":"2000","unstructured":"Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, et al. Identification of novel genes in late-onset Alzheimer\u2019s disease.Exp Gerontol 35: 1343\u20131352, 2000.","journal-title":"Exp Gerontol"},{"key":"30300302_CR64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1086\/341034","volume":"71","author":"JM Olson","year":"2002","unstructured":"Olson JM, Goddard KA, Dudek DM. A second locus for verylate-onset Alzheimer\u2019s disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region.Am J Hum Genet 71: 154\u2013161, 2002.","journal-title":"Am J Hum Genet"},{"key":"30300302_CR65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/498851","volume":"78","author":"A Grupe","year":"2006","unstructured":"Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, et al. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer\u2019s disease.Am J Hum Genet 78: 78\u201388. 2006.","journal-title":"Am J Hum Genet"},{"key":"30300302_CR66","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)63235-X","volume":"164","author":"C Schmitz","year":"2004","unstructured":"Schmitz C, Rutten BPF, Pielen A, Schafer S, Wirths O, Tremp G et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer\u2019s disease.Am J Pathol 164: 1495\u20131502, 2004.","journal-title":"Am J Pathol"},{"key":"30300302_CR67","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1073\/pnas.89.10.4378","volume":"89","author":"D Couchie","year":"1992","unstructured":"Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, Nunez J. Primary structure of high molecular weight tau present in the peripheral nervous system.Proc Natl Acad Sci USA 89: 4378\u20134381, 1992.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR68","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","volume":"101","author":"LI Binder","year":"1985","unstructured":"Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system.J Cell Biol 101: 1371\u20131378, 1985.","journal-title":"J Cell Biol"},{"key":"30300302_CR69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbadis.2004.08.007","volume":"1739","author":"M Goedert","year":"2005","unstructured":"Goedert M, Jakes R. Mutations causing neurodegenerative tauopathies.Biochim Biophys Acta 1739: 240\u2013250, 2005.","journal-title":"Biochim Biophys Acta"},{"key":"30300302_CR70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.EMBO J 8: 393\u2013399, 1989.","journal-title":"EMBO J"},{"key":"30300302_CR71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease.Neuron 3: 519\u2013526, 1989.","journal-title":"Neuron"},{"key":"30300302_CR72","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.124.5.769","volume":"124","author":"BL Goode","year":"1994","unstructured":"Goode BL, Feinstein SC. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau.J Cell Biol 124: 769\u2013782, 1994.","journal-title":"J Cell Biol"},{"key":"30300302_CR73","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1471-4159.2005.03641.x","volume":"96","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Che S, Counts SE, Mufson EJ. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease.J Neurochem 96: 1401\u20131408, 2006.","journal-title":"J Neurochem"},{"key":"30300302_CR74","first-page":"1147","volume":"3","author":"DN Drecshel","year":"1992","unstructured":"Drecshel, DN, Hyman AA, Cobb MH, Kirschner M. Modulation of the dynamic instability of tubulin assembly by the microtubule associated protein tau.Mol Biol Cell 3: 1147\u20131154, 1992.","journal-title":"Mol Biol Cell"},{"key":"30300302_CR75","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2004.10.011","volume":"1739","author":"KS Kosik","year":"2005","unstructured":"Kosik KS, Shimura H. Phosphorylated tau and the neurodegenerative foldopathies.Biochim Biophys Acta 1739: 298\u2013310, 2005.","journal-title":"Biochim Biophys Acta"},{"key":"30300302_CR76","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1074\/jbc.270.2.823","volume":"270","author":"M Morishima-Kawashima","year":"1995","unstructured":"Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, et al. Proline-directed and non-proline-directed phosphorylation of PHF-tau.J Biol Chem 270: 823\u2013829, 1995.","journal-title":"J Biol Chem"},{"key":"30300302_CR77","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","volume":"43","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, et al. Tau is a candidate gene for chromosome 17 fronto-temporal dementia.Ann Neurol 43: 815\u2013825, 1998.","journal-title":"Ann Neurol"},{"key":"30300302_CR78","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17.Nature 393: 702\u2013705, 1998.","journal-title":"Nature"},{"key":"30300302_CR79","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies.Annu Rev Neurosci 24: 1121\u20131159, 2001.","journal-title":"Annu Rev Neurosci"},{"key":"30300302_CR80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1471-4914(02)02440-1","volume":"8","author":"EM Ingram","year":"2002","unstructured":"Ingram EM, Spillantini MG. Tau gene mutations: dissecting the pathogenesis of FTDP-17.Trends Mol Med 8: 555\u2013562, 2002.","journal-title":"Trends Mol Med"},{"key":"30300302_CR81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnen\/64.5.420","volume":"64","author":"RT Mott","year":"2005","unstructured":"Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, et al. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.J Neuropathol Exp Neurol 64: 420\u2013428, 2005.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1750-3639.1998.tb00162.x","volume":"8","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.Brain Pathol 8: 387\u2013402, 1998.","journal-title":"Brain Pathol"},{"key":"30300302_CR83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004010050505","volume":"92","author":"M Bergmann","year":"1996","unstructured":"Bergmann M, Kuchelmeister K, Schmid KW, Kretzschmar HA, Schroder R. Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study.Acta Neuropathol (Berl) 92: 170\u2013179, 1996.","journal-title":"Acta Neuropathol (Berl)"},{"key":"30300302_CR84","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.Science 282: 1914\u20131917, 1998.","journal-title":"Science"},{"key":"30300302_CR85","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","volume":"86","author":"C Andorfer","year":"2003","unstructured":"Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde Y-A, et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.J Neurochem 86: 582\u2013590, 2003.","journal-title":"J Neurochem"},{"key":"30300302_CR86","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1523\/JNEUROSCI.4637-04.2005","volume":"25","author":"C Andorfer","year":"2005","unstructured":"Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.J Neurosci 25: 5446\u20135454, 2005.","journal-title":"J Neurosci"},{"key":"30300302_CR87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M006531200","volume":"276","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, Barmettler R, Nitsch RM. Tau filament formation in transgenic mice expressing P301L tau.J Biol Chem 276: 529\u2013534, 2001.","journal-title":"J Biol Chem"},{"key":"30300302_CR88","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).J Neurosci 25: 10637\u201310647, 2005.","journal-title":"J Neurosci"},{"key":"30300302_CR89","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)62274-2","volume":"166","author":"M Ikeda","year":"2005","unstructured":"Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, Murakami T, et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.Am J Pathol 166: 521\u2013531, 2005.","journal-title":"Am J Pathol"},{"key":"30300302_CR90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","volume":"26","author":"J Poirier","year":"2005","unstructured":"Poirier J. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer\u2019s disease.Neurobiol Aging 26: 355\u2013361, 2005.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR91","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","volume":"92","author":"WJ Strittmatter","year":"1995","unstructured":"Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease.Proc Natl Acad Sci USA 92: 4725\u20134727, 1995.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, et al. ApoE-4 and age at onset of Alzheimer\u2019s disease: the NIMH genetics initiative.Neurology 48: 139\u2013147, 1997.","journal-title":"Neurology"},{"key":"30300302_CR93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.WNL.0000042478.08543.F7","volume":"60","author":"DA Bennett","year":"2003","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, et al. Apolipoprotein E s4 allele, AD pathology, and the clinical expression of Alzheimer\u2019s disease.Neurology 60: 246\u2013252, 2003.","journal-title":"Neurology"},{"key":"30300302_CR94","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.Science 261: 921\u2013923, 1993.","journal-title":"Science"},{"key":"30300302_CR95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer\u2019s disease.Nat Genet 7: 180\u2013184, 1994.","journal-title":"Nat Genet"},{"key":"30300302_CR96","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.Science 240: 622\u2013630, 1988.","journal-title":"Science"},{"key":"30300302_CR97","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/JMN:23:3:225","volume":"23","author":"DK Lahiri","year":"2004","unstructured":"Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer\u2019s disease based on studies from protein, RNA, and regulatory region of the gene.J Mol Neurosci 23: 225\u2013233, 2004.","journal-title":"J Mol Neurosci"},{"key":"30300302_CR98","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0014-4886(95)90021-7","volume":"132","author":"WC Benzing","year":"1995","unstructured":"Benzing WC, Mufson EJ. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to tau and PHF in Alzheimer\u2019s disease.Exp Neurol 132: 162\u2013171, 1995.","journal-title":"Exp Neurol"},{"key":"30300302_CR99","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, et al. Binding of human apolipoprotein E to synthetic amyloid\u03b2 peptide: isoform-specific effects and implications for late-onset Alzheimer\u2019s disease.Proc Natl Acad Sci USA 90: 8098\u20138102, 1993.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR100","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B. Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein Ein vitro.Am J Pathol 145: 1030\u20131035, 1994.","journal-title":"Am J Pathol"},{"key":"30300302_CR101","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber K, Russell SJ, Mahley RW, Huang D, Saunders A, et al. Apolipoprotein E associates with A\u03b2 amyloid peptide to form novel monofibrils: isoform apoE4 associates more efficiently than apoE3.J Clin Invest 94: 860\u2013869, 1994.","journal-title":"J Clin Invest"},{"key":"30300302_CR102","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","volume":"91","author":"WJ Strittmatter","year":"1994","unstructured":"Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong L-M, Jakes R, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer\u2019s disease.Proc Natl Acad Sci USA 91: 11183\u201311186, 1994.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.Brain Res 541: 163\u2013166. 1991.","journal-title":"Brain Res"},{"key":"30300302_CR104","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00001756-199607290-00008","volume":"7","author":"F Bao","year":"1996","unstructured":"Bao F, Arai H, Matsushita S, Higuchi S, Sasaki H. Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain.NeuroReport 7: 1733\u20131739, 1996.","journal-title":"NeuroReport"},{"key":"30300302_CR105","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1523\/JNEUROSCI.23-12-05219.2003","volume":"23","author":"CA Dickey","year":"2003","unstructured":"Dickey CA, Loring JF, Montgomery J, Gordon MN, Eastman PN, Morgan D. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.J Neurosci 23: 5219\u20135226, 2003.","journal-title":"J Neurosci"},{"key":"30300302_CR106","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddh140","volume":"13","author":"PH Reddy","year":"2004","unstructured":"Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer\u2019s disease.Hum Mol Genet 13: 1225\u20131240, 2004.","journal-title":"Hum Mol Genet"},{"key":"30300302_CR107","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.Proc Natl Acad Sci USA 101: 2173\u20132178, 2004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR108","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jnr.10351","volume":"70","author":"V Colangelo","year":"2002","unstructured":"Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.J Neurosci Res 70: 462\u2013473, 2002.","journal-title":"J Neurosci Res"},{"key":"30300302_CR109","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/10445490152717541","volume":"20","author":"JF Loring","year":"2001","unstructured":"Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer\u2019s disease.DNA Cell Biol 20: 683\u2013695, 2001.","journal-title":"DNA Cell Biol"},{"key":"30300302_CR110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1023\/B:NERE.0000023615.89699.63","volume":"29","author":"WJ Lukiw","year":"2004","unstructured":"Lukiw WJ. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.Neurochem Res 29: 1287\u20131297, 2004.","journal-title":"Neurochem Res"},{"key":"30300302_CR111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2004.06.007","volume":"224","author":"A Minagar","year":"2004","unstructured":"Minagar A, Shapshak P, Duran EM, Kablingerm AS, Alexander JS, Kelley RE, et al. HIV-associated dementia, Alzheimer\u2019s disease, multiple sclerosis, and schizophrenia: gene expression review.J Neurol Sci 224: 3\u201317, 2004.","journal-title":"J Neurol Sci"},{"key":"30300302_CR112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.artmed.2004.01.008","volume":"31","author":"Walker P Roy","year":"2004","unstructured":"Roy Walker P, Smith B, Liu QY Fazel Famili A, Valdes JJ, Liu Z, et al. Data mining of gene expression changes in Alzheimer brain.Artif Intell Med 31: 137\u2013154, 2004.","journal-title":"Artif Intell Med"},{"key":"30300302_CR113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0074-7742(05)63003-6","volume":"63","author":"PL Katsel","year":"2005","unstructured":"Katsel PL, Davis KL, Haroutunian V. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer\u2019s disease.Int Rev Neurobiol 63: 41\u201382, 2005.","journal-title":"Int Rev Neurobiol"},{"key":"30300302_CR114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0163-7258(03)00086-X","volume":"100","author":"ER Marcotte","year":"2003","unstructured":"Marcotte ER, Srivastava LK, Quirion R. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer\u2019s disease.Pharmacol Ther 100: 63\u201374, 2003.","journal-title":"Pharmacol Ther"},{"key":"30300302_CR115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/15216540412331286002","volume":"56","author":"R Ricciarelli","year":"2004","unstructured":"Ricciarelli R, d\u2019Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M. Microarray analysis in Alzheimer\u2019s disease and normal aging.IUBMB Life 56: 349\u2013354, 2004.","journal-title":"IUBMB Life"},{"key":"30300302_CR116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.arr.2005.06.006","volume":"4","author":"EM Blalock","year":"2005","unstructured":"Blalock EM, Chen KC, Stromberg AJ, Norris CM, Kadish I, Kraner SD, et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer\u2019s disease: statistical reliability and functional correlation.Aging Res Rev 4: 481\u2013512. 2005.","journal-title":"Aging Res Rev"},{"key":"30300302_CR117","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymeth.2005.09.003","volume":"37","author":"SD Ginsberg","year":"2005","unstructured":"Ginsberg SD. RNA amplification strategies for small sample populations.Methods 37: 229\u2013237, 2005.","journal-title":"Methods"},{"key":"30300302_CR118","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/0-387-28942-9_4","volume-title":"Neuroanatomical tract tracing 3: Molecules-neurons-systems","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Hemby SE, Mufson EJ, Martin LJ. Cell and tissue microdissection in combination with genomic and proteomic applications. In: Neuroanatomical tract tracing 3: Molecules-neurons-systems (Zaborszky L, Wouterlood F, Lanciego JL, eds), pp 109\u2013141. New York: Springer\/Kluwer\/Plenum, 2006."},{"key":"30300302_CR119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000090906","volume":"21","author":"SE Counts","year":"2006","unstructured":"Counts SE, Chen EY, Che S, Ikonomovic MD, Wuu J, Ginsberg SD, et al. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer\u2019s disease.Dement Geriatr Cogn Disord 21: 205\u2013214, 2006.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"30300302_CR120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","volume":"97","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer\u2019s disease.J Neurochem 97: 475\u2013487, 2006.","journal-title":"J Neurochem"},{"key":"30300302_CR121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1471-4159.2003.01986.x","volume":"87","author":"WH Fasulo","year":"2003","unstructured":"Fasulo WH, Hemby SE. Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.J Neurochem 87: 205\u2013219, 2003.","journal-title":"J Neurochem"},{"key":"30300302_CR122","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1471-4159.2003.01740.x","volume":"85","author":"WX Tang","year":"2003","unstructured":"Tang WX, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims.J Neurochem 85: 911\u2013924, 2003.","journal-title":"J Neurochem"},{"key":"30300302_CR123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2004.10.003","volume":"18","author":"JG Greene","year":"2005","unstructured":"Greene JG, Dingledine R, Greenamyre JT. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.Neurobiol Dis 18: 19\u201331. 2005.","journal-title":"Neurobiol Dis"},{"key":"30300302_CR124","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1523\/JNEUROSCI.23-09-03607.2003","volume":"23","author":"F Kamme","year":"2003","unstructured":"Kamme F, Salunga R, Yu J, Tran DT, Zhu J, Luo L, et al. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity.J Neurosci 23: 3607\u20133615, 2003.","journal-title":"J Neurosci"},{"key":"30300302_CR125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/4806","volume":"5","author":"L Luo","year":"1999","unstructured":"Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, et al. Gene expression profiles of laser-captured adjacent neuronal subtypes.Nat Med 5: 117\u2013122, 1999.","journal-title":"Nat Med"},{"key":"30300302_CR126","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/labinvest.3700110","volume":"84","author":"SD Ginsberg","year":"2004","unstructured":"Ginsberg SD, Che S. Combined histochemical staining, RNA amplification, regional, and single cell analysis within the hippocampus.Lab Invest 84: 952\u2013962, 2004.","journal-title":"Lab Invest"},{"key":"30300302_CR127","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jnr.10329","volume":"69","author":"VA Vincent","year":"2002","unstructured":"Vincent VA, DeVoss JJ, Ryan HS, Murphy GM Jr. Analysis of neuronal gene expression with laser capture microdissection.J Neurosci Res 69: 578\u2013586, 2002.","journal-title":"J Neurosci Res"},{"key":"30300302_CR128","first-page":"1054","volume":"29","author":"SD Ginsberg","year":"2004","unstructured":"Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, et al. Single cell gene expression analysis: implications for neurodegenerative and neuropsychiatrie disorders.Neurochem Res 29: 1054\u20131065, 2004.","journal-title":"Neurochem Res"},{"key":"30300302_CR129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cne.20535","volume":"487","author":"SD Ginsberg","year":"2005","unstructured":"Ginsberg SD, Che S. Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons.J Comp Neurol 487: 107\u2013118, 2005.","journal-title":"J Comp Neurol"},{"key":"30300302_CR130","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.278.5342.1481","volume":"278","author":"RF Bonner","year":"1997","unstructured":"Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, et al. Laser capture microdissection: molecular analysis of tissue.Science 278: 1481\u20131483, 1997.","journal-title":"Science"},{"key":"30300302_CR131","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.274.5289.998","volume":"274","author":"MR Emmert-Buck","year":"1996","unstructured":"Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection.Science 274: 998\u20131001, 1996.","journal-title":"Science"},{"key":"30300302_CR132","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1176\/appi.ajgp.13.12.1052","volume":"13","author":"SD Ginsberg","year":"2005","unstructured":"Ginsberg SD. Glutamatergic neurotransmission expression profiling in the mouse hippocampus after perforant-path transection.Am J Geriatr Psychiatry 13: 1052\u20131061, 2005.","journal-title":"Am J Geriatr Psychiatry"},{"key":"30300302_CR133","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1023\/A:1020944502581","volume":"27","author":"SD Ginsberg","year":"2002","unstructured":"Ginsberg SD, Che S. RNA amplification in brain tissues.Neurochem Res 27: 981\u2013992, 2002.","journal-title":"Neurochem Res"},{"key":"30300302_CR134","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E","volume":"45","author":"SD Ginsberg","year":"1999","unstructured":"Ginsberg SD, Crino PB, Hemby SE, Weingarten JA, Lee VM-Y, Eberwine JH, et al. Predominance of neuronal mRNAs in individual Alzheimer\u2019s disease senile plaques.Ann Neurol 45: 174\u2013181, 1999.","journal-title":"Ann Neurol"},{"key":"30300302_CR135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A","volume":"48","author":"SD Ginsberg","year":"2000","unstructured":"Ginsberg SD, Hemby SE, Lee VM-Y, Eberwine JH, Trojanowski JQ. Expression profile of transcripts in Alzheimer\u2019s disease tangle-bearing CA1 neurons.Ann Neurol 48: 77\u201387, 2000.","journal-title":"Ann Neurol"},{"key":"30300302_CR136","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archpsyc.59.7.631","volume":"59","author":"SE Hemby","year":"2002","unstructured":"Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.Arch Gen Psychiatry 59: 631\u2013640, 2002.","journal-title":"Arch Gen Psychiatry"},{"key":"30300302_CR137","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cne.10525","volume":"456","author":"SE Hemby","year":"2003","unstructured":"Hemby SE, Trojanowski JQ, Ginsberg SD. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.J Comp Neurol 456: 176\u2013183, 2003.","journal-title":"J Comp Neurol"},{"key":"30300302_CR138","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1020952704398","volume":"27","author":"EJ Mufson","year":"2002","unstructured":"Mufson EJ, Counts SE, Ginsberg SD. Single cell gene expression profiles of nucleus basalis cholinergic neurons in Alzheimer\u2019s disease.Neurochem Res 27: 1035\u20131048, 2002.","journal-title":"Neurochem Res"},{"key":"30300302_CR139","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1073\/pnas.89.7.3010","volume":"89","author":"J Eberwine","year":"1992","unstructured":"Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, et al. Analysis of gene expression in single live neurons.Proc Natl Acad Sci USA 89: 3010\u20133014, 1992.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR140","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1523\/JNEUROSCI.21-21-08310.2001","volume":"21","author":"J Eberwine","year":"2001","unstructured":"Eberwine J, Kacharmina JE, Andrews C, Miyashiro K, McIntosh T, Becker K, et al. mRNA expression analysis of tissue sections and single cells.J Neurosci 21: 8310\u20138314, 2001.","journal-title":"J Neurosci"},{"key":"30300302_CR141","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1023\/A:1020956805307","volume":"27","author":"J Eberwine","year":"2002","unstructured":"Eberwine J, Belt B, Kacharmina JE, Miyashiro K. Analysis of subcellularly localized mRNAs usingin situ hybridization, mRNA amplification, and expression profiling.Neurochem Res 27: 1065\u20131077, 2002.","journal-title":"Neurochem Res"},{"key":"30300302_CR142","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.87.5.1663","volume":"87","author":"R Gelder van","year":"1990","unstructured":"van Gelder R, von Zastrow M, Yool A, Dement W, Barchas J, Eberwine J. Amplified RNA (aRNA) synthesized from limited quantities of heterogeneous cDNA.Proc Natl Acad Sci USA 87: 1663\u20131667, 1990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0270(97)00109-X","volume":"77","author":"JE Cheetham","year":"1997","unstructured":"Cheetham JE, Coleman PD, Chow N. Isolation of single immunohistochemically identified whole neuronal cell bodies from post-mortem human brain for simultaneous analysis of multiple gene expression.J Neurosci Methods 77: 43\u201348, 1997.","journal-title":"J Neurosci Methods"},{"key":"30300302_CR144","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.95.16.9620","volume":"95","author":"N Chow","year":"1998","unstructured":"Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD. Expression profiles of multiple genes in single neurons of Alzheimer\u2019s disease.Proc Natl Acad Sci USA 95: 9620\u20139625, 1998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"30300302_CR145","unstructured":"Mufson EJ, Counts SE, Che S, Ginsberg SD. Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease.Prog Neurobiol (in press)."},{"key":"30300302_CR146","unstructured":"Ginsberg SD, Mimics K. Functional genomics methodologies.Prog Neurobiol (in press)."},{"key":"30300302_CR147","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2144\/04375PF01","volume":"37","author":"A Dafforn","year":"2004","unstructured":"Dafforn A, Chen P, Deng G, Herrler M, Iglehart D, Koritala S, et al. Linear mRNA amplification from as little as 5 ng total RNA for global gene expression analysis.BioTechniques 37: 854\u2013857. 2004.","journal-title":"BioTechniques"},{"key":"30300302_CR148","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1373\/clinchem.2005.053694","volume":"51","author":"N Kurn","year":"2005","unstructured":"Kurn N, Chen P, Heath JD, Kopf-Sill A, Stephens KM, Wang S. Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications.Clin Chem 51: 1973\u20131981, 2005.","journal-title":"Clin Chem"},{"key":"30300302_CR149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.labinvest.3700005","volume":"84","author":"S Che","year":"2004","unstructured":"Che S, Ginsberg SD. Amplification of transcripts using terminal continuation.Lab Invest 84: 131\u2013137, 2004.","journal-title":"Lab Invest"},{"key":"30300302_CR150","unstructured":"Che S, Ginsberg SD. RNA amplification methodologies. In: Trends in RNA research. Hauppauge, NY: Nova Science Publishing (in press)."},{"key":"30300302_CR151","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/4462","volume":"21","author":"PO Brown","year":"1999","unstructured":"Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays.Nat Genet 21: 33\u201337, 1999.","journal-title":"Nat Genet"},{"key":"30300302_CR152","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0076-6879(99)03014-1","volume":"303","author":"MB Eisen","year":"1999","unstructured":"Eisen MB, Brown PO. DNA arrays for analysis of gene expression.Methods Enzymol 303: 179\u2013205, 1999.","journal-title":"Methods Enzymol"},{"key":"30300302_CR153","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.270.5235.467","volume":"270","author":"M Schena","year":"1995","unstructured":"Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray.Science 270: 467\u2013470, 1995.","journal-title":"Science"},{"key":"30300302_CR154","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/nbt1296-1675","volume":"14","author":"DJ Lockhart","year":"1996","unstructured":"Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high density oligonucleotide arrays.Nat Biotechnol 14: 1675\u20131680, 1996.","journal-title":"Nat Biotechnol"},{"key":"30300302_CR155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nurx.2006.05.005","volume":"3","author":"NE Olson","year":"2006","unstructured":"Olson NE. The microarray data analysis process: from raw data to biological significance.NeuroRx 3: 371\u2013381, 2006.","journal-title":"NeuroRx"},{"key":"30300302_CR156","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nurx.2006.05.037","volume":"3","author":"A Almudevar","year":"2006","unstructured":"Almudevar A, Klebanov LB, Qiu X, Salzman P, Yakovlev AY. Utility of correlation measures in analysis of gene expression.NeuroRx 3: 382\u2013393, 2006.","journal-title":"NeuroRx"},{"key":"30300302_CR157","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","volume":"19","author":"SP Gygi","year":"1999","unstructured":"Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast.Mol Cell Biol 19: 1720\u20131730, 1999.","journal-title":"Mol Cell Biol"},{"key":"30300302_CR158","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004010050923","volume":"96","author":"SD Ginsberg","year":"1998","unstructured":"Ginsberg SD, Galvin JE, Chiu T-S, Lee VM-Y, Masliah E, Trojanowski JQ. RNA sequestration to pathological lesions of neurodegenerative disorders.Acta Neuropathol 96: 487\u2013494, 1998.","journal-title":"Acta Neuropathol"},{"key":"30300302_CR159","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ar.1092240111","volume":"224","author":"H Topaloglu","year":"1989","unstructured":"Topaloglu H, Samat HB. Acridine orange-RNA fluorescence maturing neurons in the perinatal rat brain.Anat Rec 224: 88\u201393, 1989.","journal-title":"Anat Rec"},{"key":"30300302_CR160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","volume":"77","author":"NA Tatton","year":"1997","unstructured":"Tatton NA, Kish SJ.In situ detection of apoptotic nuclei in the substantia nigra compacta of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.Neuroscience 77: 1037\u20131048, 1997.","journal-title":"Neuroscience"},{"key":"30300302_CR161","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0197-4580(96)00108-X","volume":"17","author":"P Eikelenboom","year":"1996","unstructured":"Eikelenboom P, Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer\u2019s disease.Neurobiol Aging 17: 673\u2013680, 1996.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR162","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0317167100026135","volume":"14","author":"HB Sarnat","year":"1987","unstructured":"Sarnat HB, Curry B, Rewcastle NB, Trevenen CL. Gliosis and glioma distinguished by acridine orange.Can J Neurol Sci 14: 31\u201335, 1987.","journal-title":"Can J Neurol Sci"},{"key":"30300302_CR163","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.03.022","volume":"138","author":"GJ Burbach","year":"2004","unstructured":"Burbach GJ, Dehn D, Nagel B, Del Turco D, Deller T. Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression.J Neurosci Methods 138: 141\u2013148, 2004.","journal-title":"J Neurosci Methods"},{"key":"30300302_CR164","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/glia.20057","volume":"48","author":"GJ Burbach","year":"2004","unstructured":"Burbach GJ, Dehn D, Del Turco D, Staufenbiel M, Deller T. Laser microdissection reveals regional and cellular differences in GFAP mRNA upregulation following brain injury, axonal denervation, and amyloid plaque deposition.Glia 48: 76\u201384, 2004.","journal-title":"Glia"},{"key":"30300302_CR165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0033291700029858","volume":"21","author":"PJ Harrison","year":"1991","unstructured":"Harrison PJ, Barton AJ, Najlerahim A, McDonald B, Pearson RC. Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer\u2019s disease.Psychol Med 21: 855\u2013866, 1991.","journal-title":"Psychol Med"},{"key":"30300302_CR166","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00002093-199040200-00001","volume":"4","author":"WS Griffin","year":"1990","unstructured":"Griffin WS, Ling C, White CL, Morrison-Bogorad M. Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer\u2019s disease.Alzheimer Dis Assoc Dis 4: 69\u201378, 1990.","journal-title":"Alzheimer Dis Assoc Dis"},{"key":"30300302_CR167","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.Eur J Neurosci 22: 1942\u20131950, 2005.","journal-title":"Eur J Neurosci"},{"key":"30300302_CR168","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","volume":"168","author":"V Vogelsberg-Ragaglia","year":"2001","unstructured":"Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM. PP2A mRNA expression is quantitatively decreased in Alzheimer\u2019s disease hippocampus.Exp Neurol 168: 402\u2013412, 2001.","journal-title":"Exp Neurol"},{"key":"30300302_CR169","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1046\/j.1471-4159.1995.65062804.x","volume":"65","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Qi Z, Wang JH, Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates t protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase.J Neurochem 65: 2804\u20132807, 1995.","journal-title":"J Neurochem"},{"key":"30300302_CR170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(93)90199-U","volume":"154","author":"JN Joyce","year":"1993","unstructured":"Joyce JN, Kaeger C, Ryoo H, Goldsmith S. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer\u2019s disease.Neurosci Lett 154: 171\u2013174, 1993.","journal-title":"Neurosci Lett"},{"key":"30300302_CR171","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cne.903480105","volume":"348","author":"HL Ryoo","year":"1994","unstructured":"Ryoo HL, Joyce JN. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer\u2019s disease.J Comp Neurol 348: 94\u2013110, 1994.","journal-title":"J Comp Neurol"},{"key":"30300302_CR172","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(90)90423-9","volume":"508","author":"JO Rinne","year":"1990","unstructured":"Rinne JO, Lonnberg P, Marjamaki P. Age-dependent decline in human brain dopamine D1 and D2 receptors.Brain Res 508: 349\u2013352, 1990.","journal-title":"Brain Res"},{"key":"30300302_CR173","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410440125","volume":"44","author":"ND Volkow","year":"1998","unstructured":"Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, et al. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging.Ann Neurol 44: 143\u2013147, 1998.","journal-title":"Ann Neurol"},{"key":"30300302_CR174","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0047-6374(01)00317-7","volume":"122","author":"F Amenta","year":"2001","unstructured":"Amenta F, Mignini F, Ricci A, Sabbatini M, Tomassoni D, Tayebati SK. Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study.Mech Aging Dev 122: 2071\u20132083, 2001.","journal-title":"Mech Aging Dev"},{"key":"30300302_CR175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneumeth.2003.09.005","volume":"132","author":"RV Gutala","year":"2004","unstructured":"Gutala RV, Reddy PH. The use of real-time PCR analysis in a gene expression study of Alzheimer\u2019s disease post-mortem brains.J Neurosci Methods 132: 101\u2013107, 2004.","journal-title":"J Neurosci Methods"},{"key":"30300302_CR176","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00005072-199903000-00007","volume":"58","author":"LM Callahan","year":"1999","unstructured":"Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer\u2019s disease neurons containing neurofibrillary tangles.J Neuropathol Exp Neurol 58: 275\u2013287. 1999.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR177","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.1997.6772","volume":"150","author":"JM Heffeman","year":"1998","unstructured":"Heffeman JM, Eastwood SL, Nagy Z, Sanders MW, McDonald B, Harrison PJ. Temporal cortex synaptophysin mRNA is reduced in Alzheimer\u2019s disease and is negatively correlated with the severity of dementia.Exp Neurol 150: 235\u2013239, 1998.","journal-title":"Exp Neurol"},{"key":"30300302_CR178","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/bbrc.1997.6940","volume":"236","author":"S Shimohama","year":"1997","unstructured":"Shimohama S, Kamiya S, Taniguchi T, Akagawa K, Kimura J. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer\u2019s disease.Biochem Biophys Res Commun 236: 239\u2013242, 1997.","journal-title":"Biochem Biophys Res Commun"},{"key":"30300302_CR179","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","volume":"56","author":"CI Sze","year":"1997","unstructured":"Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer\u2019s disease.J Neuropathol Exp Neurol 56: 933\u2013944, 1997.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(00)00285-9","volume":"175","author":"CI Sze","year":"2000","unstructured":"Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer\u2019s disease brains.J Neurol Sci 175: 81\u201390, 2000.","journal-title":"J Neurol Sci"},{"key":"30300302_CR181","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1073\/pnas.88.24.10998","volume":"88","author":"AM Cataldo","year":"1991","unstructured":"Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer\u2019s disease.Proc Nail Acad Sci USA 88: 10998\u201311002, 1991.","journal-title":"Proc Nail Acad Sci USA"},{"key":"30300302_CR182","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0896-6273(95)90324-0","volume":"14","author":"AM Cataldo","year":"1995","unstructured":"Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, et al. Gene expression and cellular content of cathepsin D in Alzheimer\u2019s disease brain: evidence for early up-regulation of the endosomal-lysosomal system.Neuron 14: 671\u2013680, 1995.","journal-title":"Neuron"},{"key":"30300302_CR183","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","volume":"17","author":"AM Cataldo","year":"1997","unstructured":"Cataldo AM, Bamett JL, Picroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer\u2019s disease: neuropathologic evidence for a mechanism of increased \u03b2-amyloidogenesis.J Neurosci 17: 6142\u20136151, 1997.","journal-title":"J Neurosci"},{"key":"30300302_CR184","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, et al. Macroautophagy: a novel \u03b2-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease.J Cell Biol 171: 87\u201398, 2005.","journal-title":"J Cell Biol"},{"key":"30300302_CR185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","volume":"26","author":"RA Nixon","year":"2005","unstructured":"Nixon RA. Endosome function and dysfunction in Alzheimer\u2019s disease and other neurodegenerative diseases.Neurobiol Aging 26: 373\u2013382, 2005.","journal-title":"Neurobiol Aging"},{"key":"30300302_CR186","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1523\/JNEUROSCI.16-01-00186.1996","volume":"16","author":"AM Cataldo","year":"1996","unstructured":"Cataldo AM, Hamilton DJ, Bamett JL, Paskevich PA, Nixon RA. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer\u2019s disease.J Neurosci 16: 186\u2013199, 1996.","journal-title":"J Neurosci"},{"key":"30300302_CR187","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.902140206","volume":"214","author":"MM Mesulam","year":"1983","unstructured":"Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.J Comp Neurol 214: 170\u2013197, 1983.","journal-title":"J Comp Neurol"},{"key":"30300302_CR188","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction.Science 217: 408\u2013414, 1982.","journal-title":"Science"},{"key":"30300302_CR189","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0959-4388(99)80024-5","volume":"9","author":"MG Baxter","year":"1999","unstructured":"Baxter MG, Chiba AA. Cognitive functions of the basal fore-brain.Curr Opin Neurobiol 9: 178\u2013183, 1999.","journal-title":"Curr Opin Neurobiol"},{"key":"30300302_CR190","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease.Lancet 2: 1403, 1976.","journal-title":"Lancet"},{"key":"30300302_CR191","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","volume":"64","author":"LM Bierer","year":"1995","unstructured":"Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, et al. Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: relative importance of the cholinergic deficits.J Neurochem 64: 749\u2013760, 1995.","journal-title":"J Neurochem"},{"key":"30300302_CR192","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"DS Auld","year":"2002","unstructured":"Auld DS, Komecook TJ, Bastianetto S, Quirion R. Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.Prog Neurobiol 68: 209\u2013245, 2002.","journal-title":"Prog Neurobiol"},{"key":"30300302_CR193","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.arr.2005.06.009","volume":"4","author":"JE Galvin","year":"2005","unstructured":"Galvin JE, Ginsberg SD. Expression profiling in the aging brain: a perspective.Aging Res Rev 4: 529\u2013547, 2005.","journal-title":"Aging Res Rev"},{"key":"30300302_CR194","first-page":"264","volume":"18","author":"JE Galvin","year":"2004","unstructured":"Galvin JE, Ginsberg SD. Expression profiling and pharmacotherapeutic development in the central nervous system.Alzheimer Dis Assoc Disord 18: 264\u2013269, 2004.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"30300302_CR195","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20100","volume":"55","author":"M Mesulam","year":"2004","unstructured":"Mesulam M, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.Ann Neurol 55: 815\u2013828, 2004.","journal-title":"Ann Neurol"},{"key":"30300302_CR196","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jnen\/64.4.263","volume":"64","author":"SE Counts","year":"2005","unstructured":"Counts SE, Mufson EJ. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer\u2019s disease.J Neuropathol Exp Neurol 64: 263\u2013272, 2005.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR197","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A","volume":"427","author":"EJ Mufson","year":"2000","unstructured":"Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer\u2019s disease.J Comp Neurol 427: 19\u201330, 2000.","journal-title":"J Comp Neurol"},{"key":"30300302_CR198","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.59.2.198","volume":"59","author":"DA Bennett","year":"2002","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons.Neurology 59: 198\u2013205, 2002.","journal-title":"Neurology"},{"key":"30300302_CR199","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1046\/j.1471-4159.2000.0741749.x","volume":"74","author":"ME King","year":"2000","unstructured":"King ME, Gamblin TC, Kuret J, Binder LI. Differential assembly of human tau isoforms in the presence of arachidonic acid.J Neurochem 74: 1749\u20131757, 2000.","journal-title":"J Neurochem"},{"key":"30300302_CR200","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1074\/jbc.M413490200","volume":"280","author":"SF Levy","year":"2005","unstructured":"Levy SF, Leboeuf AC, Massie MR, Jordan MA, Wilson L, Feinstein SC. Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners: implications for neurodegeneration.J Biol Chem 280: 13520\u201313528, 2005.","journal-title":"J Biol Chem"},{"key":"30300302_CR201","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V","volume":"46","author":"CB Chambers","year":"1999","unstructured":"Chambers CB, Lee JM, Troncoso JC, Reich S, Muma NA. Over-expression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer\u2019s disease.Ann Neurol 46: 325\u2013332, 1999.","journal-title":"Ann Neurol"},{"key":"30300302_CR202","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2990.2003.00463.x","volume":"29","author":"R Silva de","year":"2003","unstructured":"de Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.Neuropathol Appl Neurobiol 29: 288\u2013302, 2003.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"30300302_CR203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-003-0671-8","volume":"105","author":"T Arai","year":"2003","unstructured":"Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, et al. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration.Acta Neuropathol (Berl) 105: 489\u2013498, 2003.","journal-title":"Acta Neuropathol (Berl)"},{"key":"30300302_CR204","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnen\/64.3.209","volume":"64","author":"Y Fujino","year":"2005","unstructured":"Fujino Y, Wang DS, Thomas N, Espinoza M, Davies P, Dickson DW. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.J Neuropathol Exp Neurol 64: 209\u2013214, 2005.","journal-title":"J Neuropathol Exp Neurol"},{"key":"30300302_CR205","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0002-9440(10)64390-8","volume":"161","author":"V Zhukareva","year":"2002","unstructured":"Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, et al. Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer\u2019s disease, and Pick\u2019s disease: a comparative study.Am J Pathol 161: 1135\u20131141, 2002.","journal-title":"Am J Pathol"},{"key":"30300302_CR206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-0618(03)00068-1","volume":"26","author":"EJ Mufson","year":"2003","unstructured":"Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.J Chem Neuroanat 26: 233\u2013242, 2003.","journal-title":"J Chem Neuroanat"},{"key":"30300302_CR207","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair.Annu Rev Neurosci 24: 1217\u20131281, 2001.","journal-title":"Annu Rev Neurosci"},{"key":"30300302_CR208","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20233","volume":"56","author":"SE Counts","year":"2004","unstructured":"Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer\u2019s disease.Ann Neurol 56: 520\u2013531, 2004.","journal-title":"Ann Neurol"},{"key":"30300302_CR209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<1::AID-JNR1>3.0.CO;2-2","volume":"59","author":"C Colantuoni","year":"2000","unstructured":"Colantuoni C, Purcell AE, Bouton CM, Pevsner J. High throughput analysis of gene expression in the human brain.J Neurosci Res 59: 1\u201310, 2000.","journal-title":"J Neurosci Res"},{"key":"30300302_CR210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0959-4388(99)00022-7","volume":"9","author":"T Serafini","year":"1999","unstructured":"Serafini T. Of neurons and gene chips.Curr Opin Neurobiol 9: 641\u2013644, 1999.","journal-title":"Curr Opin Neurobiol"}],"container-title":["NeuroRX"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurx.2006.05.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:22:04Z","timestamp":1586996524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1016\/j.nurx.2006.05.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":210,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["30300302"],"URL":"https:\/\/doi.org\/10.1016\/j.nurx.2006.05.007","relation":{},"ISSN":["1545-5343"],"issn-type":[{"value":"1545-5343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}